Economics of the Pharmaceutical Industry

High profits justified in terms of generating funds for drug development but relatively low proportion of revenues going to research

Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs investment in drug development

Research often funded by public purse (universities) but profits go to industry.